Malaria research and its influence on anti-malarial drug policy in Malawi: a case study

In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether.

See original article here: 

Malaria research and its influence on anti-malarial drug policy in Malawi: a case study